Type(s) of Cancer
Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Botryoid-Type Embryonal Rhabdomyosarcoma, Childhood Embryonal Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Non-Metastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Untreated Childhood Rhabdomyosarcoma
Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Botryoid-Type Embryonal Rhabdomyosarcoma, Childhood Embryonal Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Non-Metastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Untreated Childhood Rhabdomyosarcoma
Study Phase
Phase 3
Study Completion Date
December 2014
December 2014
NCT00354835Uploaded 10-06-2020
Access via NCI by Request
PDS UID: nci-data-431
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)
Files: NCT00354835-D1



Data DictionaryNCT00354835-D1-Data-Dictionary_3.pdf

DATANCT00354835-D1-Dataset_3.csv

OTHERREADME.pdf
Files: NCT00354835-D2



Data DictionaryNCT00354835-D2-Data-Dictionary_4.pdf

DATANCT00354835-D2-Dataset_3.csv

OTHERREADME.pdf
Files: NCT00354835-D3



Data DictionaryNCT00354835-D3-Data-Dictionary_4.pdf

DATANCT00354835-D3-Dataset_2.csv

OTHERREADME.pdf